Related Experiment Videos
Magnesium therapy for acute myocardial infarction
1Department of Medicine, Shaare Zedek Medical Center, Jerusalem, Israel.
Comprehensive Therapy
|January 1, 1988
Summary
Acute myocardial infarction patients face high risk of fatal arrhythmias. Magnesium (Mg) infusion effectively prevents these dangerous heart rhythms, reducing in-hospital mortality by stabilizing potassium (K) and magnesium levels.
Area of Science:
- Cardiology
- Electrophysiology
- Biochemistry
Background:
- Acute myocardial infarction (AMI) presents a significant risk of life-threatening ventricular arrhythmias within 24 hours.
- Cellular injury during AMI leads to potassium (K) and magnesium (Mg) ion efflux from damaged cells.
- Elevated K and Mg levels in peripheral blood lymphocytes correlate with arrhythmia incidence and severity.
Purpose of the Study:
- To investigate the association between serum cation levels and ventricular arrhythmias post-AMI.
- To evaluate the efficacy of magnesium infusion in preventing these arrhythmias and reducing mortality.
Main Methods:
- Monitoring of K and Mg ion levels in peripheral blood lymphocytes of AMI patients.
- Correlation analysis between cation levels and the occurrence of ventricular arrhythmias.
- Clinical trial assessing the impact of continuous magnesium infusion on arrhythmia incidence and in-hospital mortality.
Main Results:
- High K levels were associated with an increased incidence of ventricular arrhythmias.
- High Mg levels demonstrated a protective effect against arrhythmias.
- Continuous Mg infusion significantly reduced arrhythmia occurrence and lowered in-hospital mortality.
Conclusions:
- Magnesium plays a crucial role in preventing ventricular arrhythmias following acute myocardial infarction.
- Magnesium therapy is a highly effective strategy for reducing mortality in AMI patients at risk for arrhythmias.